Stability of the in vivo P388 leukemia model in evaluation of antitumor activity of natural products
- PMID: 4016772
Item in Clipboard
Stability of the in vivo P388 leukemia model in evaluation of antitumor activity of natural products
Cancer Treat Rep.
1985 Jun.
Abstract
The stability of the P388 mouse leukemia model over 15 years was examined. Eleven natural products and one synthetic compound (5-FU) tested repetitively under the same conditions of dose and schedule were associated with no significant change in their activity. The P388 model, used in conjunction with other in vivo and in vitro tumor models, continues to be of value in the anticancer drug screening process.
Similar articles
-
Relationship between in vitro tumor stem cell assay and in vivo antitumor activity using the P388 leukemia.Int J Cell Cloning. 1988 Jan;6(1):60-8. doi: 10.1002/stem.5530060107. Int J Cell Cloning. 1988. PMID: 3339266
-
Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models.Cancer Res. 1985 Jan;45(1):32-9. Cancer Res. 1985. PMID: 3917372
-
[Results of random screening of possible antineoplastic agents in Japan using mouse cancer. 3].Gan To Kagaku Ryoho. 1984 Sep;11(9 Pt 2):1899-2096. Gan To Kagaku Ryoho. 1984. PMID: 6497404 Japanese. No abstract available.
-
Is the P388 murine tumor no longer adequate as a drug discovery model?Invest New Drugs. 1987;5(1):3-20. doi: 10.1007/BF00217664. Invest New Drugs. 1987. PMID: 3298130 Review. No abstract available.
-
Leukemia: A model for drug development.Clin Cancer Res. 1997 Dec;3(12 Pt 2):2598-604. Clin Cancer Res. 1997. PMID: 9815664 Review.